Effect of probiotic-fermented, genetically modified soy milk on hypercholesterolemia in hamsters

Journal of Microbiology, Immunology and Infection

Volumn 47, Issue 1, 2014, Pages 1-8

  Tsai, Tsung Yu ^a   Chen, Li Ying ^a   Pan, Tzu Ming ^b  

^a FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Atherosclerosis; Genetically modified; Hypercholesterolemia; Probiotic fermentation; Soy milk

Indexed keywords

ATHEROSCLEROSIS; GENETICALLY MODIFIED; HYPERCHOLESTEROLEMIA; PROBIOTIC-FERMENTATION; SOY MILK;

ANIMALS; AORTA; ATHEROSCLEROSIS; BLOOD CHEMICAL ANALYSIS; CRICETINAE; DIET; FECES; FERMENTATION; HYPERCHOLESTEROLEMIA; LIPIDS; MALE; MESOCRICETUS; PLANTS, GENETICALLY MODIFIED; PLAQUE, ATHEROSCLEROTIC; PROBIOTICS; SOY MILK; SOYBEANS; TREATMENT OUTCOME;

EID: 84894417316     PISSN: 16841182     EISSN: 19959133     Source Type: Journal    
DOI: 10.1016/j.jmii.2012.05.009     Document Type: Article

References (30)

1. ISAAA brief. Global status of commercialized biotech/GM crops: 2010. Ithaca, NY, USA: ISAA, 2011. Available at: [accessed 9.02.12]. http://www.isaaa.org/resources/publications/briefs/42/.
2. Liu J.R., Lin C.W. Production of kefir from soy milk with or without added glucose, lactose, or sucrose. J Food Sci 2000, 65:716-719.
3. Tomat A.L., Costa MdlÁ., Arranz C.T. Zinc restriction during different periods of life: influence in renal and cardiovascular diseases. Nutr 2011, 27:392-398.
4. Chen J.R., Liu S.M., Yang S.C., Suetsuna K. Soy milk intake is associated with plasma and liver lipid profiles in rats fed a high-cholesterol diet. Nutr 2004, 20:929-933.
5. Kano M., Takayanagi T., Harada K., Sawada S., Ishikawa F. Bioavailability of isoflavones after ingestion of soy beverages in healthy adults. J Nutr 2006, 136:2291-2296.
6. Setchell K.D., Brown N.M., Zimmer-Nechemias L., Brashear W.T., Wolfe B.E., Kirschner A.S., et al. Evidence for lack of absorption of soy isoflavone glycosides in humans, supporting the crucial role of intestinal metabolism for bioavailability. Am J Clin Nutr 2002, 76:447-453.
7. Otieno D.O., Ashton J.F., Shah N.P. Evaluation of enzymic potential for biotransformation of isoflavone phytoestrogen in soy milk by Bifidobacterium animalis, Lactobacillus acidophilus and Lactobacillus casei. Food Res Int 2006, 39:394-407.
8. Yoshida S.H. The safety of genetically modified soybeans: evidence and regulation. Food Drug Law J 2000, 55:193-208.
9. Padgette S.R., Taylor N.B., Nida D.L., Bailey M.R., MacDonald J., Holden L.R. The composition of glyphosate-tolerant soybean seeds is equivalent to that of conventional soybeans. J Nutr 1996, 126:702-716.
10. Domingo J.L., Giné Bordonaba J. A literature review on the safety assessment of genetically modified plants. Environ Int 2011, 37:734-742.
11. Chen M.F. The gender gap in food choice motives as determinants of consumers' attitudes toward GM foods in Taiwan. British Food J 2011, 113:697-709.
12. Tsai T.Y., Chu L.H., Lee C.L., Pan T.M. Atherosclerosis-preventing activity of lactic acid bacteria-fermented milk-soy milk supplemented with Momordica charantia. J Agric Food Chem 2009, 57:2065-2071.
13. Huang C.C., Pan T.M. Event-specific real-time detection and quantification of genetically modified roundup ready soybean. J Agric Food Chem 2005, 53:3833-3839.
14. AOAC Official methods of analysis of the association of official analytical chemists 1984, Association of Official Analytical Chemists, Gaithersburg, MA, USA.
15. DuBois M., Gilles K.A., Hamilton J.K., Rebers P.A., Smith F. Colorimetric method for determination of sugars and related substances. Anal Chem 1956, 28:350-356.
16. Lin S.J., Lay H.L., Wu S.T., Tseng F.S. Contents of certain isoflavones in Glycine dolichocarpa, G. tabacina and G. tomentella collected in Taiwan. J Food Drug Anal 2005, 13:260-266.
17. Boyd E. The growth of the surface area of human body 1935, University of Minnesota Press, Minneapolis, MN.
18. Lee C.L., Tsai T.Y., Wang J.J., Pan T.M. Invivo hypolipidemic effects and safety of low dosage Monascus powder in a hamster model of hyperlipidemia. App Microbiol Biotech 2006, 70:533-540.
19. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18:499-502.
20. Mabile L., Fitoussi G., Periquet B., Schmitt A., Salvayre R., Negre-Salvayre A. alpha-Tocopherol and trolox block the early intracellular events (TBARS and calcium rises) elicited by oxidized low density lipoproteins in cultured endothelial cells. Free Radic Biol Med 1995, 19:177-187.
21. Miller N.J., Rice-Evans C., Davies M.J., Gopinathan V., Milner A. Anovel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin Sci 1993, 84:407-412.
22. Hagen M.K., Lehenbauer-Ludke A.R., Paludo A.C., Schenkel P., Goncalves L., Fernandes T.G., et al. Diet with isolated soy protein reduces oxidative stress and preserves ventricular function in rats with myocardial infarction. Nutr Metab Cardiovasc Dis 2009, 19:91-97.
23. Center Environmental Risk Assessment. GM Crop Database. Ithaca, NY, USA: ISAA, 2012. Available at: [accessed 9.02.12]. http://cera-gmc.org/index.php?action=gm_crop_database.
24. Wells J.M., Mercenier A. Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria. Nat Rev Microbiol 2008, 6:349-362.
25. Kratz M. Dietary cholesterol, atherosclerosis and coronary heart disease. Handbook Exp Pharmacol 2005, 170:195-213.
26. Jessup W., Dean R.T., de Whalley C.V., Rankin S.M., Leake D.S. The role of oxidative modification and antioxidants in LDL metabolism and atherosclerosis. Adv Expi Med Biol 1990, 264:139-142.
27. Liczmanski A.E. Oxygen toxicity. II. Defense mechanisms. Postepy Biochem 1988, 34:293-310.
28. Rufer C.E., Kulling S.E. Antioxidant activity of isoflavones and their major metabolites using different invitro assays. J Agric Food Chem 2006, 54:2926-2931.
29. Je J.Y., Qian Z.J., Kim S.K. Antioxidant peptide isolated from muscle protein of bullfrog, Rana catesbeianaShaw. J Med Food 2007, 10:401-407.
30. Je J.-Y., Qian Z.-J., Byun H.-G., Kim S- K. Purification and characterization of an antioxidant peptide obtained from tuna backbone protein by enzymatic hydrolysis. Process Biochem 2007, 42:840-846.